Intrasense, French specialist in medical imaging solutions, announces that its new oncology follow-up solution, DUOnco™ Unity, has obtained CE marking under the European Medical Device Regulation (MDR 2017/745).

Intrasense, French expert in AI-enhanced medical imaging solutions facilitating diagnosis, decision-making and therapeutic follow-up, announces the termination of the proposed sale of the technological assets, intellectual property, customer and partner contracts, and the teams dedicated to the Myrian business to EDL.

Intrasense, a French expert in AI-enhanced medical imaging solutions that facilitate diagnosis, decision-making, and treatment monitoring, announces the postponement of the release of its 2026 half-year results and financial report, originally scheduled for September 15, 2026.

Intrasense, a French expert in medical imaging solutions facilitating and securing diagnosis, decision-making, and treatment follow-up, announces the publication of its 2026 half-year results and progress on its strategic roadmap.

Intrasense, a French specialist in AI-enhanced medical imaging solutions supporting diagnosis, clinical decision-making and therapeutic monitoring ("Intrasense" or the "Company"), announces that it has received a firm and irrevocable offer from EDL for the acquisition of its Myrian® business.